![]() |
Code of Federal Regulations (Last Updated: July 5, 2024) |
![]() |
Title 10 - Energy |
![]() |
Chapter I - Nuclear Regulatory Commission |
![]() |
Part 35 - Medical Use of Byproduct Material |
![]() |
Subpart C - General Technical Requirements |
§ 35.53 - Measurement of dosages of unsealed byproduct material for medical use.
-
A licensee shall:
(a) Measure the activity of each dosage of a photon-emitting radionuclide prior to medical use.
(b) Measure, by direct measurement or by combination of measurements and calculations, the activity of each dosage of an alpha- or a beta-emitting radionuclide prior to medical use, except for unit dosages obtained from a manufacturer or preparer licensed pursuant to 10 CFR 32.72 or equivalent Agreement State requirements;
(c) Retain a record of the measurements required by this section for three years. To satisfy this requirement, the record must contain the:
(1) Generic name, trade name, or abbreviation of the radiopharmaceutical, its lot number, and expiration dates and the radionuclide;
(2) Patient's or human research subject's name, and identification number if one has been assigned;
(3) Prescribed dosage and activity of the dosage at the time of measurement, or a notation that the total activity is less than 1.1 megabecquerels (30 microcuries);
(4) Date and time of the measurement; and
(5) Initials of the individual who made the record.